Inspira Technologies Oxy BHN Ltd Ordinary Shares IINN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IINN is a good fit for your portfolio.
News
-
Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
-
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
-
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
-
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
-
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
-
Inspira™ Technologies Reports Full Year 2023 Financial Results
-
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
-
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
Trading Information
- Previous Close Price
- $1.88
- Day Range
- $1.86–1.92
- 52-Week Range
- $0.76–2.49
- Bid/Ask
- $1.90 / $1.92
- Market Cap
- $32.86 Mil
- Volume/Avg
- 5,158 / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 42
Valuation
|
Metric
|
IINN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.13 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IINN
|
|---|---|
Quick Ratio | 1.69 |
Current Ratio | 2.61 |
Interest Coverage | — |
Quick Ratio
IINN
Profitability
|
Metric
|
IINN
|
|---|---|
Return on Assets (Normalized) | −81.30% |
Return on Equity (Normalized) | −109.25% |
Return on Invested Capital (Normalized) | −99.98% |
Return on Assets
IINN
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Mfrpxnpz | Dsrqf | $183.9 Bil | |
SYK
| Stryker Corp | Scvjtgmmg | Rkvr | $128.0 Bil | |
MDT
| Medtronic PLC | Bkpjvzdkj | Wtgrw | $106.5 Bil | |
BSX
| Boston Scientific Corp | Zbclvzv | Hdswqfw | $105.6 Bil | |
EW
| Edwards Lifesciences Corp | Jwqmsbmcf | Thybvrp | $51.0 Bil | |
DXCM
| DexCom Inc | Svbsfwytm | Zcn | $50.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mjxwccgg | Cgtj | $24.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Crgzdmbjf | Skvrd | $24.5 Bil | |
ALGN
| Align Technology Inc | Xffnpmhv | Wxlsf | $21.3 Bil | |
PODD
| Insulet Corp | Sfbcgwrc | Trqmjn | $12.0 Bil |